Increased surface P2X4 receptor regulates anxiety and memory in P2X4 internalization-defective knock-in mice.


Journal

Molecular psychiatry
ISSN: 1476-5578
Titre abrégé: Mol Psychiatry
Pays: England
ID NLM: 9607835

Informations de publication

Date de publication:
02 2021
Historique:
received: 16 09 2019
accepted: 12 12 2019
revised: 10 12 2019
pubmed: 9 1 2020
medline: 15 5 2021
entrez: 9 1 2020
Statut: ppublish

Résumé

ATP signaling and surface P2X4 receptors are upregulated selectively in neurons and/or glia in various CNS disorders including anxiety, chronic pain, epilepsy, ischemia, and neurodegenerative diseases. However, the cell-specific functions of P2X4 in pathological contexts remain elusive. To elucidate P2X4 functions, we created a conditional transgenic knock-in P2X4 mouse line (Floxed P2X4mCherryIN) allowing the Cre activity-dependent genetic swapping of the internalization motif of P2X4 by the fluorescent mCherry protein to prevent constitutive endocytosis of P2X4. By combining molecular, cellular, electrophysiological, and behavioral approaches, we characterized two distinct knock-in mouse lines expressing noninternalized P2X4mCherryIN either exclusively in excitatory forebrain neurons or in all cells natively expressing P2X4. The genetic substitution of wild-type P2X4 by noninternalized P2X4mCherryIN in both knock-in mouse models did not alter the sparse distribution and subcellular localization of P2X4 but increased the number of P2X4 receptors at the surface of the targeted cells mimicking the pathological increased surface P2X4 state. Increased surface P2X4 density in the hippocampus of knock-in mice altered LTP and LTD plasticity phenomena at CA1 synapses without affecting basal excitatory transmission. Moreover, these cellular events translated into anxiolytic effects and deficits in spatial memory. Our results show that increased surface density of neuronal P2X4 contributes to synaptic deficits and alterations in anxiety and memory functions consistent with the implication of P2X4 in neuropsychiatric and neurodegenerative disorders. Furthermore, these conditional P2X4mCherryIN knock-in mice will allow exploring the cell-specific roles of P2X4 in various physiological and pathological contexts.

Identifiants

pubmed: 31911635
doi: 10.1038/s41380-019-0641-8
pii: 10.1038/s41380-019-0641-8
doi:

Substances chimiques

Receptors, Purinergic P2X4 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

629-644

Références

Khakh BS, North RA. Neuromodulation by extracellular ATP and P2X receptors in the CNS. Neuron. 2012;76:51–69.
pubmed: 23040806 pmcid: 4064466 doi: 10.1016/j.neuron.2012.09.024
Rodrigues RJ, Almeida T, Richardson PJ, Oliveira CR, Cunha RA. Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y2, and/or P2Y4 receptors in the rat hippocampus. J Neurosci. 2005;25:6286–95.
pubmed: 16000618 pmcid: 6725280 doi: 10.1523/JNEUROSCI.0628-05.2005
Rubio ME, Soto F. Distinct localization of P2X receptors at excitatory postsynaptic specializations. J Neurosci. 2001;21:641–53.
pubmed: 11160443 pmcid: 6763822 doi: 10.1523/JNEUROSCI.21-02-00641.2001
Kaczmarek-Hajek K, Zhang J, Kopp R, Grosche A, Rissiek B, Saul A, et al. Re-evaluation of neuronal P2X7 expression using novel mouse models and a P2X7-specific nanobody. eLife. 2018;7:e36217.
pubmed: 30074479 pmcid: 6140716 doi: 10.7554/eLife.36217
Jo YH, Schlichter R. Synaptic corelease of ATP and GABA in cultured spinal neurons. Nat Neurosci. 1999;2:241–5.
pubmed: 10195216 doi: 10.1038/6344
Mori M, Heuss C, Gahwiler BH, Gerber U. Fast synaptic transmission mediated by P2X receptors in CA3 pyramidal cells of rat hippocampal slice cultures. J Physiol. 2001;535:115–23.
pubmed: 11507162 pmcid: 2278762 doi: 10.1111/j.1469-7793.2001.t01-1-00115.x
Gordon GR, Baimoukhametova DV, Hewitt SA, Rajapaksha WR, Fisher TE, Bains JS. Norepinephrine triggers release of glial ATP to increase postsynaptic efficacy. Nat Neurosci. 2005;8:1078–86.
pubmed: 15995701 doi: 10.1038/nn1498
Pougnet JT, Toulme E, Martinez A, Choquet D, Hosy E, Boue-Grabot E. ATP P2X receptors downregulate AMPA receptor trafficking and postsynaptic efficacy in hippocampal neurons. Neuron. 2014;83:417–30.
pubmed: 25033184 doi: 10.1016/j.neuron.2014.06.005
Lalo U, Palygin O, Rasooli-Nejad S, Andrew J, Haydon PG, Pankratov Y. Exocytosis of ATP from astrocytes modulates phasic and tonic inhibition in the neocortex. PLoS Biol. 2014;12:e1001747.
pubmed: 24409095 pmcid: 3883644 doi: 10.1371/journal.pbio.1001747
Boué-Grabot E, Pankratov Y. Modulation of central synapses by astrocyte-released ATP and postsynaptic P2X receptors. Neural Plast. 2017;2017:9454275.
Illes P, Verkhratsky A. Purinergic neurone-glia signalling in cognitive-related pathologies. Neuropharmacology. 2016;104:62–75.
pubmed: 26256423 doi: 10.1016/j.neuropharm.2015.08.005
Kawate T, Michel JC, Birdsong WT, Gouaux E. Crystal structure of the ATP-gated P2X(4) ion channel in the closed state. Nature. 2009;460:592–8.
pubmed: 19641588 pmcid: 2720809 doi: 10.1038/nature08198
Egan TM, Khakh BS. Contribution of calcium ions to P2X channel responses. J Neurosci. 2004;24:3413–20.
pubmed: 15056721 pmcid: 6730036 doi: 10.1523/JNEUROSCI.5429-03.2004
Suurväli J, Boudinot P, Kanellopoulos J, Rüütel Boudinot S. P2X4: a fast and sensitive purinergic receptor. Biomed J. 2017;40:245–56.
Xu J, Bernstein AM, Wong A, Lu XH, Khoja S, Yang XW, et al. P2X4 receptor reporter mice: sparse brain expression and feeding-related presynaptic facilitation in the arcuate nucleus. J Neurosci. 2016;36:8902–20.
pubmed: 27559172 pmcid: 4995303 doi: 10.1523/JNEUROSCI.1496-16.2016
Yeung D, Kharidia R, Brown SC, Gorecki DC. Enhanced expression of the P2X4 receptor in Duchenne muscular dystrophy correlates with macrophage invasion. Neurobiol Dis. 2004;15:212–20.
pubmed: 15006691 doi: 10.1016/j.nbd.2003.10.014
Sim JA, Chaumont S, Jo J, Ulmann L, Young MT, Cho K, et al. Altered hippocampal synaptic potentiation in P2X4 knock-out mice. J Neurosci. 2006;26:9006–9.
pubmed: 16943557 pmcid: 6675341 doi: 10.1523/JNEUROSCI.2370-06.2006
Pankratov Y, Lalo U, Krishtal OA, Verkhratsky A P2X receptors and synaptic plasticity. Neuroscience. 2009;158:137–148.
Cavaliere F, Florenzano F, Amadio S, Fusco FR, Viscomi MT, D'Ambrosi N, et al. Up-regulation of P2X2, P2X4 receptor and ischemic cell death: prevention by P2 antagonists. Neuroscience. 2003;120:85–98.
pubmed: 12849743 doi: 10.1016/S0306-4522(03)00228-8
Franke H, Illes P. Involvement of P2 receptors in the growth and survival of neurons in the CNS. Pharm Ther. 2006;109:297–324.
doi: 10.1016/j.pharmthera.2005.06.002
Burnstock G. Purinergic signalling and disorders of the central nervous system. Nat Rev Drug Disco. 2008;7:575–90.
doi: 10.1038/nrd2605
Apolloni S, Montilli C, Finocchi P, Amadio S. Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events. FEBS J. 2009;276:354–64.
pubmed: 19076216 doi: 10.1111/j.1742-4658.2008.06796.x
Volonte C, Apolloni S, Parisi C, Amadio S. Purinergic contribution to amyotrophic lateral sclerosis. Neuropharmacology. 2016;104:180–93.
pubmed: 26514402 doi: 10.1016/j.neuropharm.2015.10.026
Beggs S, Trang T, Salter MW. P2X4R+ microglia drive neuropathic pain. Nat Neurosci. 2012;15:1068–73.
pubmed: 22837036 pmcid: 5023423 doi: 10.1038/nn.3155
Varma R, Chai Y, Troncoso J, Gu J, Xing H, Stojilkovic SS, et al. Amyloid-beta induces a caspase-mediated cleavage of P2X4 to promote purinotoxicity. Neuromolecular Med. 2009;11:63–75.
pubmed: 19562525 pmcid: 2735730 doi: 10.1007/s12017-009-8073-2
Casanovas A, Hernandez S, Tarabal O, Rossello J, Esquerda JE. Strong P2X4 purinergic receptor-like immunoreactivity is selectively associated with degenerating neurons in transgenic rodent models of amyotrophic lateral sclerosis. J Comp Neurol. 2008;506:75–92.
pubmed: 17990272 doi: 10.1002/cne.21527
Bobanovic LK, Royle SJ, Murrell-Lagnado RD. P2X receptor trafficking in neurons is subunit specific. J Neurosci. 2002;22:4814–24.
pubmed: 12077178 pmcid: 6757758 doi: 10.1523/JNEUROSCI.22-12-04814.2002
Royle SJ, Bobanovic LK, Murrell-Lagnado RD. Identification of a non-canonical tyrosine-based endocytic motif in an ionotropic receptor. J Biol Chem. 2002;277:35378–85.
pubmed: 12105201 doi: 10.1074/jbc.M204844200
Qureshi OS, Paramasivam A, Yu JC, Murrell-Lagnado RD. Regulation of P2X4 receptors by lysosomal targeting, glycan protection and exocytosis. J Cell Sci. 2007;120:3838–49.
pubmed: 17940064 doi: 10.1242/jcs.010348
Royle SJ, Qureshi OS, Bobanovic LK, Evans PR, Owen DJ, Murrell-Lagnado RD. Non-canonical YXXGPhi endocytic motifs: recognition by AP2 and preferential utilization in P2X4 receptors. J Cell Sci. 2005;118:3073–80.
pubmed: 15985462 doi: 10.1242/jcs.02451
Toulme E, Garcia A, Samways D, Egan TM, Carson MJ, Khakh BS. P2X4 receptors in activated C8-B4 cells of cerebellar microglial origin. J Gen Physiol. 2010;135:333–53.
pubmed: 20231374 pmcid: 2847917 doi: 10.1085/jgp.200910336
Cao Q, Zhong XZ, Zou Y, Murrell-Lagnado R, Zhu MX, Dong XP. Calcium release through P2X4 activates calmodulin to promote endolysosomal membrane fusion. J Cell Biol. 2015;209:879–94.
pubmed: 26101220 pmcid: 4477861 doi: 10.1083/jcb.201409071
Huang P, Zou Y, Zhong XZ, Cao Q, Zhao K, Zhu MX, et al. P2X4 forms functional ATP-activated cation channels on lysosomal membranes regulated by luminal pH. J Biol Chem. 2014;289:17658–67.
pubmed: 24817123 pmcid: 4067200 doi: 10.1074/jbc.M114.552158
Robinson LE, Murrell-Lagnado RD. The trafficking and targeting of P2X receptors. Front Cell Neurosci. 2013;7:233.
pubmed: 24319412 pmcid: 3837535
Andries M, Van Damme P, Robberecht W, Van Den Bosch L. Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol Dis. 2007;25:8–16.
pubmed: 17045808 doi: 10.1016/j.nbd.2006.08.018
Khoja S, Huynh N, Asatryan L, Jakowec MW, Davies DL. Reduced expression of purinergic P2X4 receptors increases voluntary ethanol intake in C57BL/6J mice. Alcohol. 2018;68:63–70.
pubmed: 29477921 doi: 10.1016/j.alcohol.2017.09.004
Wyatt LR, Finn DA, Khoja S, Yardley MM, Asatryan L, Alkana RL, et al. Contribution of P2X4 receptors to ethanol intake in male C57BL/6 mice. Neurochem Res. 2014;39:1127–39.
pubmed: 24671605 pmcid: 4031031 doi: 10.1007/s11064-014-1271-9
Tsuda M, Shigemoto-Mogami Y, Koizumi S, Mizokoshi A, Kohsaka S, Salter MW, et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature. 2003;424:778–83.
pubmed: 12917686 doi: 10.1038/nature01786
Ulmann L, Hatcher JP, Hughes JP, Chaumont S, Green PJ, Conquet F, et al. Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J Neurosci. 2008;28:11263–8.
pubmed: 18971468 pmcid: 6671487 doi: 10.1523/JNEUROSCI.2308-08.2008
Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature. 2005;438:1017–21.
pubmed: 16355225 doi: 10.1038/nature04223
Ulmann L, Hirbec H, Rassendren F. P2X4 receptors mediate PGE2 release by tissue-resident macrophages and initiate inflammatory pain. EMBO J. 2010;29:2290–300.
pubmed: 20562826 pmcid: 2910276 doi: 10.1038/emboj.2010.126
Jo YH, Donier E, Martinez A, Garret M, Toulme E, Boue-Grabot E. Cross-talk between P2X4 and gamma-aminobutyric acid, type A receptors determines synaptic efficacy at a central synapse. J Biol Chem. 2011;286:19993–20004.
pubmed: 21482824 pmcid: 3103373 doi: 10.1074/jbc.M111.231324
Toulme E, Soto F, Garret M, Boue-Grabot E. Functional properties of internalization-deficient P2X4 receptors reveal a novel mechanism of ligand-gated channel facilitation by ivermectin. Mol Pharm. 2006;69:576–87.
doi: 10.1124/mol.105.018812
Chamma I, Heubl M, Chevy Q, Renner M, Moutkine I, Eugene E, et al. Activity-dependent regulation of the K/Cl transporter KCC2 membrane diffusion, clustering, and function in hippocampal neurons. J Neurosci. 2013;33:15488–503.
pubmed: 24068817 pmcid: 6618451 doi: 10.1523/JNEUROSCI.5889-12.2013
Ray A, Dittel BN. Isolation of mouse peritoneal cavity cells. J Vis Exp. 2010.
Berthet A, Porras G, Doudnikoff E, Stark H, Cador M, Bezard E, et al. Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesia. J Neurosci. 2009;29:4829–35.
pubmed: 19369551 pmcid: 6665326 doi: 10.1523/JNEUROSCI.5884-08.2009
Bertin E, Martinez A. Boue-Grabot E. P2X Electrophysiology and Surface Trafficking in Xenopus Oocytes. Methods Mol Biol. 2020;2041:243–59.
pubmed: 31646494 doi: 10.1007/978-1-4939-9717-6_18
Belzung C. Hippocampal mossy fibres: implication in novelty reactions or in anxiety behaviours? Behav Brain Res. 1992;51:149–55.
pubmed: 1466781 doi: 10.1016/S0166-4328(05)80208-6
Renner MJ, Bennett AJ, White JC. Age and sex as factors influencing spontaneous exploration and object investigation by preadult rats (Rattus norvegicus). J Comp Psychol. 1992;106:217–27.
pubmed: 1395491 doi: 10.1037/0735-7036.106.3.217
Pellow S, File SE. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharm Biochem Behav. 1986;24:525–9.
doi: 10.1016/0091-3057(86)90552-6
Dellu F, Contarino A, Simon H, Koob GF, Gold LH. Genetic differences in response to novelty and spatial memory using a two-trial recognition task in mice. Neurobiol Learn Mem. 2000;73:31–48.
pubmed: 10686122 doi: 10.1006/nlme.1999.3919
Bergmann P, Garcia de Paco A, Rissiek B, Menzel S, Dubberke G, Hua J et al. Generation and characterization of specific monoclonal antibodies and Nanobodies directed against the ATP-gated channel P2X4. Front Cell Neurosci. 2019;13:498.
Lê KT, Villeneuve P, Ramjaun AR, McPherson PS, Beaudet A, Seguela P. Sensory presynaptic and widespread somatodendritic immunolocalization of central ionotropic P2X ATP receptors. Neuroscience. 1998;83:177–90.
pubmed: 9466408 doi: 10.1016/S0306-4522(97)00365-5
Buell G, Lewis C, Collo G, North RA, Surprenant A. An antagonist-insensitive P2X receptor expressed in epithelia and brain. EMBO J. 1996;15:55–62.
pubmed: 8598206 pmcid: 449917 doi: 10.1002/j.1460-2075.1996.tb00333.x
Ulmann L, Levavasseur F, Avignone E, Peyroutou R, Hirbec H, Audinat E, et al. Involvement of P2X4 receptors in hippocampal microglial activation after status epilepticus. Glia. 2013;61:1306–19.
pubmed: 23828736 doi: 10.1002/glia.22516
Dulawa SC, Grandy DK, Low MJ, Paulus MP, Geyer MA. Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J Neurosci. 1999;19:9550–6.
pubmed: 10531457 pmcid: 6782928 doi: 10.1523/JNEUROSCI.19-21-09550.1999
Nicole O, Hadzibegovic S, Gajda J, Bontempi B, Bem T, Meyrand P. Soluble amyloid beta oligomers block the learning-induced increase in hippocampal sharp wave-ripple rate and impair spatial memory formation. Sci Rep. 2016;6:22728.
pubmed: 26947247 pmcid: 4779992 doi: 10.1038/srep22728
Layhadi JA, Turner J, Crossman D, Fountain SJ. ATP evokes Ca(2+) responses and CXCL5 secretion via P2X4 receptor activation in human monocyte-derived macrophages. J Immunol. 2018;200:1159–68.
pubmed: 29255078 doi: 10.4049/jimmunol.1700965
Tsien JZ, Chen DF, Gerber D, Tom C, Mercer EH, Anderson DJ, et al. Subregion- and cell type-restricted gene knockout in mouse brain. Cell. 1996;87:1317–26.
pubmed: 8980237 doi: 10.1016/S0092-8674(00)81826-7
Stokes L, Layhadi JA, Bibic L, Dhuna K, Fountain SJ. P2X4 receptor function in the nervous system and current breakthroughs in pharmacology. Front Pharm. 2017;8:291.
doi: 10.3389/fphar.2017.00291
Franklin KM, Asatryan L, Jakowec MW, Trudell JR, Bell RL, Davies DL. P2X4 receptors (P2X4Rs) represent a novel target for the development of drugs to prevent and/or treat alcohol use disorders. Front Neurosci. 2014;8:176.
pubmed: 25009459 pmcid: 4068020 doi: 10.3389/fnins.2014.00176
Huganir RL, Nicoll RA. AMPARs and synaptic plasticity: the last 25 years. Neuron. 2013;80:704–17.
pubmed: 24183021 pmcid: 4195488 doi: 10.1016/j.neuron.2013.10.025
Baxter AW, Choi SJ, Sim JA, North RA. Role of P2X4 receptors in synaptic strengthening in mouse CA1 hippocampal neurons. Eur J Neurosci. 2011;34:213–20.
pubmed: 21749490 pmcid: 3763203 doi: 10.1111/j.1460-9568.2011.07763.x
Pankratov YV, Lalo UV, Krishtal OA. Role for P2X receptors in long-term potentiation. J Neurosci. 2002;22:8363–9.
pubmed: 12351710 pmcid: 6757784 doi: 10.1523/JNEUROSCI.22-19-08363.2002
Jo YH, Boue-Grabot E. Interplay between ionotropic receptors modulates inhibitory synaptic strength. Commun Integr Biol. 2011;4:706–9.
pubmed: 22446533 pmcid: 3306337 doi: 10.4161/cib.17291
Wyatt LR, Godar SC, Khoja S, Jakowec MW, Alkana RL, Bortolato M et al. Sociocommunicative and sensorimotor impairments in male P2X4-deficient mice. Neuropsychopharmacology. 2013;38:1993–2002.
Mayford M, Bach ME, Huang YY, Wang L, Hawkins RD, Kandel ER. Control of memory formation through regulated expression of a CaMKII transgene. Science. 1996;274:1678–83.
pubmed: 8939850 doi: 10.1126/science.274.5293.1678
Parkhurst CN, Yang G, Ninan I, Savas JN, Yates JR 3rd, Lafaille JJ, et al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell. 2013;155:1596–609.
pubmed: 24360280 pmcid: 4033691 doi: 10.1016/j.cell.2013.11.030
Hafner S, Wagner K, Weber S, Groger M, Wepler M, McCook O, et al. Role of the purinergic receptor P2XR4 after blunt chest trauma in cigarette smoke-exposed mice. Shock. 2017;47:193–9.
pubmed: 27559703 doi: 10.1097/SHK.0000000000000726
Chen H, Xia Q, Feng X, Cao F, Yu H, Song Y, et al. Effect of P2X4R on airway inflammation and airway remodeling in allergic airway challenge in mice. Mol Med Rep. 2016;13:697–704.
pubmed: 26648454 doi: 10.3892/mmr.2015.4622
Yang T, Shen JB, Yang R, Redden J, Dodge-Kafka K, Grady J, et al. Novel protective role of endogenous cardiac myocyte P2X4 receptors in heart failure. Circ Heart Fail. 2014;7:510–8.
pubmed: 24622244 pmcid: 4289151 doi: 10.1161/CIRCHEARTFAILURE.113.001023
Pettengill MA, Marques-da-Silva C, Avila ML, d'Arc dos Santos Oliveira S, Lam VW, Ollawa I, et al. Reversible inhibition of Chlamydia trachomatis infection in epithelial cells due to stimulation of P2X(4) receptors. Infect Immun. 2012;80:4232–8.
pubmed: 22988022 pmcid: 3497399 doi: 10.1128/IAI.00441-12
Gonzales E, Julien B, Serriere-Lanneau V, Nicou A, Doignon I, Lagoudakis L, et al. ATP release after partial hepatectomy regulates liver regeneration in the rat. J Hepatol. 2010;52:54–62.
pubmed: 19914731 doi: 10.1016/j.jhep.2009.10.005

Auteurs

Eléonore Bertin (E)

Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France.
CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France.

Thomas Deluc (T)

Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France.
CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France.
Department of Neurology and Neurosurgery, Montreal Neurological Institute, Alan Edwards Centre for Research on Pain, McGill University, Montreal, QC, H3A 2B4, Canada.

Kjara S Pilch (KS)

Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France.
CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France.

Audrey Martinez (A)

Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France.
CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France.

Johan-Till Pougnet (JT)

Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France.
CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France.

Evelyne Doudnikoff (E)

Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France.
CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France.

Anne-Emilie Allain (AE)

Université de Bordeaux, Institut de Neurosciences Cognitives et Intégratives d'Aquitaine, UMR5287, F-33000, Bordeaux, France.
CNRS, Institut de Neurosciences Cognitives et Intégratives d'Aquitaine, UMR5287, F-33000, Bordeaux, France.

Philine Bergmann (P)

Institute of Immunology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, D-20246, Hamburg, Germany.

Marion Russeau (M)

INSERM UMR-S 1270, Sorbonne Université, Institut du Fer à Moulin, 75005, Paris, France.

Estelle Toulmé (E)

Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France.
CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France.

Erwan Bezard (E)

Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France.
CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France.

Friedrich Koch-Nolte (F)

Institute of Immunology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, D-20246, Hamburg, Germany.

Philippe Séguéla (P)

Department of Neurology and Neurosurgery, Montreal Neurological Institute, Alan Edwards Centre for Research on Pain, McGill University, Montreal, QC, H3A 2B4, Canada.

Sabine Lévi (S)

INSERM UMR-S 1270, Sorbonne Université, Institut du Fer à Moulin, 75005, Paris, France.

Bruno Bontempi (B)

Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France.
CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France.

François Georges (F)

Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France.
CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France.

Sandrine S Bertrand (SS)

Université de Bordeaux, Institut de Neurosciences Cognitives et Intégratives d'Aquitaine, UMR5287, F-33000, Bordeaux, France.
CNRS, Institut de Neurosciences Cognitives et Intégratives d'Aquitaine, UMR5287, F-33000, Bordeaux, France.

Olivier Nicole (O)

Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France.
CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France.

Eric Boué-Grabot (E)

Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. eric.boue-grabot@u-bordeaux.fr.
CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. eric.boue-grabot@u-bordeaux.fr.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH